| Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants and Children 6 to 24 Months of Age (NCT02948127) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-09-01 |
| Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant. (NCT02909036) | Memorial Sloan Kettering Cancer Center | 2016-09-01 |
| A Study of EDP 305 in Healthy Subjects and Subjects With Presumptive NAFLD (NCT02918929) | Enanta Pharmaceuticals, Inc | 2016-09-01 |
| A Phase I Trial of HS-10241 in Solid Tumors (NCT02759640) | Atridia Pty Ltd. | 2016-09-01 |
| SF2a-TT15 Conjugate Vaccine in Healthy Adult Volunteers (NCT02797236) | Institut Pasteur | 2016-09-01 |
| The Effects of Video Modeling of Audiological Testing on Pediatric Patient Compliance (NCT03002363) | Northwestern University | 2016-09-01 |
| A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Conjugate Vaccine in Adults (NCT02892812) | LG Life Sciences | 2016-09-01 |
| A Clinical Trial to Evaluate a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults (NCT02804711) | Jiangsu Province Centers for Disease Control and Prevention | 2016-09-01 |
| A Phase I Pharmacokinetic Study of Fluticasone Furoate /Umeclidinium Bromide/Vilanterol (100/62.5/25 Microgram [mcg]) After Single and Repeat Dose Administration From a Dry Powder Inhaler in Healthy Chinese Subjects (NCT02837380) | GlaxoSmithKline | 2016-09-01 |
| SF2000SD Clinical Trial in Zambia (NCT02941159) | Tropical Diseases Research Centre, Zambia | 2016-09-01 |
| Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant (NCT02947854) | PCI Biotech AS | 2016-09-01 |
| Bioequivalence Study of Gefitinib Tablets Under Fed Conditions (NCT03050177) | Hunan Kelun Pharmaceutical Co., Ltd. | 2016-09-01 |
| Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers (NCT03822884) | Bio Sidus SA | 2016-09-01 |
| A Pilot Study of Low Field Magnetic Stimulation in PTSD: Three Daily Treatments (NCT02545192) | Mclean Hospital | 2016-09-01 |
| Pharmacokinetic Study of SCT800 in Previously Treated Patients With Hemophilia A (NCT02888223) | Sinocelltech Ltd. | 2016-09-01 |
| Oral Docetaxel (ModraDoc/r) in Combination With Hormonal Treatment and Radiation Therapy in High-risk Prostate Cancer (NCT03066154) | The Netherlands Cancer Institute | 2016-09-01 |
| A Study to Evaluate Cenerimod in Healthy Male Subjects (NCT02914223) | Viatris Innovation GmbH | 2016-09-01 |
| TA-65 Pharmacokinetic Study (NCT02731807) | NYU Langone Health | 2016-09-01 |
| Study of Irinotecan and AZD1775, a Selective Wee 1 Inhibitor, in RAS or BRAF Mutated, Second-line Metastatic Colorectal Cancer (NCT02906059) | NYU Langone Health | 2016-09-01 |
| Dose-Escalation Study of Ponatinib, a FLT3 Inhibitor, With and Without Combination of 5-Azacytidine, in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML) (NCT02829840) | M.D. Anderson Cancer Center | 2016-09-01 |
| A Study to Assess the Potential for Pre-systemic Inhibition of CYP3A by Idebenone Using Midazolam as a Substrate (NCT02887443) | Santhera Pharmaceuticals | 2016-09-01 |
| A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations (NCT02950064) | Placon Therapeutics | 2016-09-01 |
| The Effect of Brimonidine on Intraocular Pressure When Dilating Routine Patients (NCT03139708) | Wake Forest University Health Sciences | 2016-09-01 |
| Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants (NCT02912234) | Bristol-Myers Squibb | 2016-09-01 |
| Safety and Efficacy Study of Vaccine Schedule With Ad26.Mos.HIV and MVA-Mosaic in Human Immunodeficiency Virus (HIV)-Infected Adults (NCT02919306) | Janssen Vaccines & Prevention B.V. | 2016-09-01 |
| Cerebral Pharmacodynamic Effects of 5-HT1B Receptor Stimulation (NCT02932488) | Gitte Moos Knudsen | 2016-09-01 |
| Safety Study of Intravitreal EBI-031 Given as a Single or Repeat Injection to Subjects With Diabetic Macular Edema (NCT02842541) | Eleven Biotherapeutics | 2016-09-01 |
| Steroids and Surfactant in Extremely Low Gestation Age Infants Dose Escalation Trial (NCT02907593) | Cynthia McEvoy | 2016-09-01 |
| Autologous Bone Marrow-Derived Stem Cell Therapy for Motor Neuron Disease (NCT03067857) | Stem Cells Arabia | 2016-09-01 |
| A Study of Talazoparib in Patients With Advanced Solid Tumors (NCT03070548) | Pfizer | 2016-09-01 |
| Scalpel Versus Electrocautery for Surgical Skin Incision in Open Carpal Tunnel Release (NCT02791529) | Turku University Hospital | 2016-09-01 |
| PD-1 Knockout Engineered T Cells for Muscle-invasive Bladder Cancer (NCT02863913) | Peking University | 2016-09-01 |
| A Study of JNJ-54767414 (Daratumumab) in Combination With Lenalidomide and Dexamethasone in Japanese Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-dose Therapy and Autologous Stem Cell Transplantation (NCT02918331) | Janssen Pharmaceutical K.K. | 2016-09-01 |
| CLAM Chemotherapy With PBSC Support for Relapsed Patients After Allogeneic Stem Cell Transplantation (NCT02910752) | Shanghai Jiao Tong University School of Medicine | 2016-09-01 |
| Macrolide Therapy to Improve Forced Expiratory Volume in 1 Second in Adults With Sickle Cell Disease (NCT02960503) | Vanderbilt University | 2016-09-01 |
| Intraoperative Nasal Insulin Effect on Plasma and CSF Insulin Concentration and Blood Glucose (NCT02729064) | Hiroaki Sato, MD., PhD. | 2016-09-01 |
| Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008 (NCT02955693) | Almirall, S.A. | 2016-09-01 |
| Study of Hepatitis C Treatment During Pregnancy (NCT02683005) | Catherine Chappell | 2016-09-01 |
| Afatinib and Gemcitabine/Nab-paclitaxel in Metastatic Pancreatic Cancer (NCT02975141) | PD Dr. med. Volker Heinemann | 2016-09-01 |
| Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer (NCT02933944) | Targovax ASA | 2016-09-01 |
| Cannabinoid Medication for Adults With OCD (NCT02911324) | New York State Psychiatric Institute | 2016-09-01 |
| Safety, Tolerability and PK of BTK Inhibitor DTRMWXHS-12 in Patients With B-Cell Lymphomas (NCT02891590) | Zhejiang DTRM Biopharma | 2016-09-01 |
| Study for the Use of TKIs for Treatment of Cognitive Decline Due to Degenerative Dementias (NCT02921477) | Neurological Associates of West Los Angeles | 2016-09-01 |
| Study of Autologous Bone Marrow Derived Mononuclear Cells for Treatment of Ebstein Anomaly (NCT02914171) | Timothy J. Nelson | 2016-09-01 |
| A Study to Assess the Safety, Tolerability and Potential Efficacy of a Tracheal Replacement Consisting of a Tissue-engineered Tracheal Scaffold With Seeded Mesenchymal Cells (NCT02949414) | Cell Therapy Catapult | 2016-09-01 |
| ATX-GD-59 in Patients With Graves Disease Not Treated With Anti-thyroid Therapy (NCT02973802) | Apitope International NV | 2016-09-01 |
| The Safety and Efficacy Study of HU-014 Versus Botox® in Subject With Moderate to Severe Glabellar Lines (NCT02961673) | Huons Co., Ltd. | 2016-09-01 |
| "E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study" (NCT02957630) | Estetra | 2016-09-01 |
| Relative Bioavailability Study of a Fixed-dose Combination Dolutegravir/Abacavir/Lamivudine Dispersible Tablet (NCT02893488) | ViiV Healthcare | 2016-09-01 |
| Tocilizumab in Schizophrenia (NCT02874573) | Brian Miller | 2016-09-01 |
| Positron Emission Tomography (PET) Imaging Studies With NIS Reporter (NCT02907073) | Mayo Clinic | 2016-09-01 |
| A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors (NCT02880371) | Pfizer | 2016-09-01 |
| Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH (NCT02893826) | Edge Therapeutics Inc | 2016-09-01 |
| Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal Angioplasty (NCT02915796) | Shanghai 10th People's Hospital | 2016-09-01 |
| Safety Study of EF-022 in Adults With Recurrent Respiratory Papillomatosis (RRP) (NCT02854761) | Efranat Ltd. | 2016-09-01 |
| Open-label Study of Safety, Tolerability and Pharmacokinetics of Multiple Doses of BI-CON-02 in Patients With HER2-positive Metastatic Breast Cancer, Previously Treated With Trastuzumab (NCT03062007) | Biointegrator LLC | 2016-09-01 |
| Safety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell Lymphomas (NCT02900716) | Zhejiang DTRM Biopharma | 2016-09-01 |
| Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease (NCT02907567) | Cognition Therapeutics | 2016-09-01 |
| A Phase 1 Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057 (NCT02916537) | Cancer Targeted Technology | 2016-09-01 |
| Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies (NCT02812056) | M.D. Anderson Cancer Center | 2016-09-01 |
| Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors (NCT02926768) | Checkpoint Therapeutics, Inc. | 2016-09-01 |
| Adductor Canal Block Versus Patient Controlled Analgesia, in the Surgical Stress Response for Anterior Cruciate Ligament Repair (NCT04797546) | Pontificia Universidad Catolica de Chile | 2016-09-01 |
| Prevalence of Spontaneous Pneumothorax in BHD (NCT02916992) | Hans Smit | 2016-09-01 |
| Clinical Trial to Assess the Safety and Pharmacokinetics of HUG116 Tablet and Viread® Tablet in Healthy Male Volunteers (NCT02902523) | Huons Co., Ltd. | 2016-09-01 |
| Double-Blind Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD) (NCT02911597) | Stanford University | 2016-09-01 |
| Phase 1 Study of BXQ-350 in Adult Patients With Advanced Solid Tumors (NCT02859857) | Bexion Pharmaceuticals, Inc. | 2016-09-01 |
| Socket Preservation Using Autogenous Bone Graft Versus MPM (NCT03008538) | Cairo University | 2016-09-01 |
| Intervention to Encourage HIV Testing and Counseling Among Adolescents (NCT02812329) | Yale University | 2016-09-01 |
| Biological Vaccine: Semi-allogeneic Human Fibroblasts (MRC-5) Transfected With DNA (NCT02211027) | Robert Ferris | 2016-09-01 |
| School Based Physical Activity Interventions and Its Impact on Wellbeing and Educational Outcomes (NCT03548350) | Queen's University, Belfast | 2016-09-01 |
| Evaluation of the Safety and Potential Therapeutic Effects of CB-AC-02 in Patients With Alzheimer's Disease (NCT02899091) | CHABiotech CO., Ltd | 2016-09-01 |
| IV Dosage Form of LCB01-0371 Phase I Study in Healthy Male Volunteers (NCT02882789) | LigaChem Biosciences, Inc. | 2016-09-01 |
| Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome (NCT02909972) | Aileron Therapeutics, Inc. | 2016-09-01 |
| A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate Cancer (NCT02747342) | Atridia Pty Ltd. | 2016-09-01 |
| Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy (NCT03078621) | Stem Cells Arabia | 2016-09-01 |
| Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides (NCT02890368) | Pfizer | 2016-09-01 |
| Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU (NCT02998996) | Eurocine Vaccines AB | 2016-09-01 |
| Pharmacokinetic Study of E7080/Lenvatinib in Chinese Patients With Unresectable Hepatocellular Carcinoma (HCC) (NCT02953743) | Eisai Co., Ltd. | 2016-09-01 |
| Gonadotrophin Releasing Hormone Agonist Addition for Luteal Support in In-vitro Fertilization and Embryo Transfer Cycles (NCT02908438) | Northwest Women's and Children's Hospital, Xi'an, Shaanxi | 2016-09-01 |
| Anti-PD-1 Alone or Combined With Autologous DC-CIK Cell Therapy in Advanced Solid Tumors (NCT03190811) | Capital Medical University | 2016-09-01 |
| Combination Transfer of αCD19-TCRz-41BB and αCD22-TCRz-41BB CAR-T Cells for B-cell Hematologic Malignancy (NCT02903810) | Xuzhou Medical University | 2016-09-01 |
| Ibuprofen Bioavailability Trial With Oral Single Dose Administration. (NCT03018015) | SocraTec R&D GmbH | 2016-09-01 |
| Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder (NCT02901587) | H. Lundbeck A/S | 2016-09-01 |
| Evaluating the Safety and Immunogenicity of a Live Attenuated Virus Vaccine to Prevent Influenza H3N2v Disease (NCT02883426) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-09-01 |
| A Study to Assess the Impact of Speed and Site of Subcutaneous Injection on Pain, Tolerability, Safety, and Pharmacokinetics of Gantenerumab in Healthy Participants (NCT02882009) | Hoffmann-La Roche | 2016-08-31 |
| A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas (NCT02875223) | Celgene | 2016-08-31 |
| Stem Cells Therapy for Corneal Blindness (NCT02948023) | L.V. Prasad Eye Institute | 2016-08-31 |
| A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of BCD-100 in Patients With Advanced Solid Tumors (NCT03050047) | Biocad | 2016-08-30 |
| A Single-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Hantaan Puumala Virus DNA Vaccine (NCT02776761) | U.S. Army Medical Research and Development Command | 2016-08-30 |
| RRx-001 in Combination With Irinotecan in Metastatic or Advanced Cancer (PAYLOAD) (NCT02801097) | EpicentRx, Inc. | 2016-08-30 |
| Safety and Efficacy Evaluation of IM19 CAR-T Cells (NCT03142646) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2016-08-30 |
| Ascending Dose and Exploratory Expansion Study of DS-3032b, an Oral MDM2 Inhibitor, in Subjects With Relapsed and/or Refractory Multiple Myeloma (NCT02579824) | M.D. Anderson Cancer Center | 2016-08-30 |
| Lesinurad/Allopurinol 200/300 FDC Tablets Bioequivalence (NCT02888054) | Ardea Biosciences, Inc. | 2016-08-30 |
| Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer (NCT02520778) | National Cancer Institute (NCI) | 2016-08-30 |
| An Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's Lymphoma (NCT02783300) | GlaxoSmithKline | 2016-08-30 |
| A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study (NCT02875548) | Epizyme, Inc. | 2016-08-30 |
| Tremelimumab and Durvalumab in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery (NCT02754856) | M.D. Anderson Cancer Center | 2016-08-29 |
| Nivolumab in Combination With Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT02812667) | Lyudmila Bazhenova, M.D. | 2016-08-29 |
| A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer (NCT02677116) | Eli Lilly and Company | 2016-08-29 |
| Sequential Optimization of Dose and Schedule of PfSPZ Vaccine (NCT02704533) | Sanaria Inc. | 2016-08-29 |